サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1548114

ペプチド合成の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Peptide Synthesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 181 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ペプチド合成の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ペプチド合成市場の世界需要は、2023年の6億9,069万米ドルから2032年には22億6,390万米ドル近くの市場規模に達すると推定され、調査期間2024～2032年のCAGRは14.1%です。

ペプチドは、抗酸化作用、ホルモン作用、抗菌作用、臨床診断など幅広い生物学的機能を持ち、成長因子としても作用します。さらに、高い特異性、広い化学的空間、合成の容易さ、生物学的活性、低毒性、すぐに入手可能であることから、潜在的な医薬品有効成分として医薬品開発にも利用されています。ペプチド分子はまた、心血管疾患、がん、呼吸器疾患などを含むいくつかの疾患の治療にも利用されています。ペプチド分子は、ペプチド生産における様々な技術の進歩により、栄養産業や医療産業で大きな勢いを得ました。例えば、化学合成はペプチド合成のための伝統的で広く使用されている技術と考えられているが、このプロセスは特異性に欠け、環境負荷のリスクを増大させる。そのため、ペプチド合成に酵素技術が採用されるようになりました。

市場力学

医薬品の生産におけるペプチドの使用量の増加が市場の成長を後押ししています。ペプチドは、多様な生物学的機能を持つ特異性の高い活性薬であり、幅広い治療セグメントで使用されています。糖尿病、腫瘍、肥満は、ペプチドが数10億米ドルの利益を生み出す3大治療セグメントです。米国国立がん研究所の調査研究によると、2018年には米国で1,735,350人のがん患者が診断されました。さらに、国民の間で座りがちなライフスタイルが増加しているため、肥満の可能性が高まっています。したがって、疾病の増加は、世界のペプチド合成市場の成長を後押しします。さらに、ペプチド合成市場における研究開発活動の増加も市場成長に寄与しています。世界の健康課題を克服するために、研究参入企業が増加し、先進的で革新的なバイオベース製品への投資が活発化していることも、市場成長にプラスの影響を与えています。しかし、ペプチド合成の過程における汚染の問題は、規制基準のアップグレードの欠如と相まって、市場拡大の抑制要因となっています。様々な企業がペプチド製造のための先端技術を開発しており、今後数年間で市場に有利な機会を生み出すと予想されます。例えば、New England Peptide Inc.は、Pep Trendシステムという独自のソフトウェア・プログラムを使用して、カスタムペプチドを設計・製造しています。

レポートでは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。

さらに、これらのツールは、ペプチド合成の世界市場における各用途/製品セグメントを包括的に評価することもできます。

市場セグメンテーション

ペプチド合成市場全体は、製品、用途、技術、エンドユーザーに細分化されています。本レポートでは、これらのサブセットを地域別に分析しています。この調査はマーケティング担当者に情報を提供し、製品やサービスの対象層を特定するのに役立ちます。

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるペプチド合成市場の現在と将来の需要に重点を置いた地域セグメンテーションをカバーしています。さらに、このレポートでは、すべての主要地域における個々の用途セグメントの需要に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 ペプチド合成-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 ペプチド合成の世界市場分析：製品別

  • 製品別概要
  • 実績データと予測データ
  • 製品別分析
  • 装置（ペプチド合成装置、凍結乾燥装置、クロマトグラフィー装置、その他）
  • 試薬・消耗品
  • その他

第6章 ペプチド合成の世界市場分析：技術別

  • 技術別概要
  • 実績データと予測データ
  • 技術別分析
  • 固相ペプチド合成（SPPS）
  • 液相ペプチド合成（LPPS）
  • ハイブリッド技術

第7章 ペプチド合成の世界市場分析：用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • 治療（がん、代謝、心血管障害、呼吸器、GIT（胃腸障害）、感染症、疼痛、皮膚科、中枢神経系、腎臓、その他）
  • 診断
  • 研究

第8章 ペプチド合成の世界市場分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • 製薬・バイオテクノロジー企業
  • 受託開発・製造機関/受託研究機関
  • 学術・研究機関

第9章 ペプチド合成の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第10章 ペプチド合成企業の競合情勢

  • ペプチド合成市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Genscript Biotech
  • Merck KGaA
  • Bachem Holdings
  • Biotage
  • CEM Corporation
  • Thermo Fisher
  • Creative Diagnostics
  • Polypeptide Group
  • Syngene
  • PuroSynth
  • Lonza
  • MP Biomedicals And Novo Nordisk A/S.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others) Market Sales By Geography (USD MN)
  • Reagents & Consumables Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Solid Phase Peptide Synthesis (SPPS) Market Sales By Geography (USD MN)
  • Liquid Phase Peptide Synthesis (LPPS) Market Sales By Geography (USD MN)
  • Hybrid Technology Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) Market Sales By Geography (USD MN)
  • Diagnosis Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Contract Development & Manufacturing Organization/Contract Research Organization Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Peptide Synthesis Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Peptide Synthesis Report
  • Market Research Process
  • Market Research Methodology
  • Global Peptide Synthesis Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others) Market Sales By Geography (USD MN)
  • Reagents & Consumables Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Solid Phase Peptide Synthesis (SPPS) Market Sales By Geography (USD MN)
  • Liquid Phase Peptide Synthesis (LPPS) Market Sales By Geography (USD MN)
  • Hybrid Technology Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) Market Sales By Geography (USD MN)
  • Diagnosis Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Contract Development & Manufacturing Organization/Contract Research Organization Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11211390

The global demand for Peptide Synthesis Market is presumed to reach the market size of nearly USD 2263.9 Million by 2032 from USD 690.69 Million in 2023 with a CAGR of 14.1% under the study period 2024 - 2032.

Peptides possess broad range of biological functions such as anti-oxidant properties, hormonal functions, antimicrobial agents, clinical diagnosis, and also act as growth factors. Furthermore, they are also used in drug development as potential active pharmaceutical ingredients owing to their high specificity, large chemical space, ease of synthesis, biological activity, low toxicity, and ready availability. They are also exploited in the treatment of several diseases including cardiovascular diseases, cancer, respiratory disorders, and others. Peptide molecules gained immense momentum in nutrition and healthcare industries attributed to the various technological advancements in the peptide production. For instance, chemical synthesis is considered as the traditional and widely used technology for peptide synthesis; however, the process lacked specificity and increased the risk of environmental burdens. Therefore, this caused the adoption of enzymatic technology for peptide synthesis.

Market Dynamics

Escalating usage of peptides in the production of pharmaceutical drugs propels the market growth. Peptides are highly specific and active drugs with diverse biological functions that are used in a broad range of therapeutic areas. Diabetes, oncology, and obesity are the three major therapeutic areas in which peptides generate profits in billions of dollars. According to the research study by National Cancer Institute, 1,735,350 cancer cases were diagnosed in the U.S in 2018. Additionally, owing to the growing sedentary lifestyle among populace increases the chances of obesity. Therefore, rising disease conditions boost the growth of global peptide synthesis market. Moreover, the increase in research & development activities in the peptide synthesis market also contributes to the market growth. The rising participation of research entities and investment for the advanced and innovative bio-based products in order to overcome the global health challenges positively influences the market growth. However, contamination issues during the course of peptide synthesis coupled with lack of upgradation in regulatory standards acts as a restrain for the market progression. Various companies are developing advanced technologies for peptide production, and it is anticipated to create lucrative opportunities for the market in the coming years. For example, New England Peptide Inc. uses a unique software program named Pep Trend system, to design and produce custom peptides.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of peptide synthesis.

Market Segmentation

The entire peptide synthesis market has been sub-categorized into product, application, technology and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Product

  • Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others)
  • Reagents & Consumables
  • Other

By Technology

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

By Application

  • Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others)
  • Diagnosis
  • Research

By End-use

  • Pharmaceutical & Biotechnology Companies
  • Contract Development & Manufacturing Organization/Contract Research Organization
  • Academic & Research Institutes
  • Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for peptide synthesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the peptide synthesis market include Genscript Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, Thermo Fisher, Creative Diagnostics, Polypeptide Group, Syngene, PuroSynth, Lonza, MP Biomedicals and Novo Nordisk A/S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PEPTIDE SYNTHESIS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others) Historic and Forecast Sales By Regions
  • 5.5. Reagents & Consumables Historic and Forecast Sales By Regions
  • 5.6. Other Historic and Forecast Sales By Regions

6. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Technology
  • 6.4. Solid Phase Peptide Synthesis (SPPS) Historic and Forecast Sales By Regions
  • 6.5. Liquid Phase Peptide Synthesis (LPPS) Historic and Forecast Sales By Regions
  • 6.6. Hybrid Technology Historic and Forecast Sales By Regions

7. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) Historic and Forecast Sales By Regions
  • 7.5. Diagnosis Historic and Forecast Sales By Regions
  • 7.6. Research Historic and Forecast Sales By Regions

8. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-use
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By End-use
  • 8.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.5. Contract Development & Manufacturing Organization/Contract Research Organization Historic and Forecast Sales By Regions
  • 8.6. Academic & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PEPTIDE SYNTHESIS COMPANIES

  • 10.1. Peptide Synthesis Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF PEPTIDE SYNTHESIS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Genscript Biotech
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Merck KGaA
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Bachem Holdings
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Biotage
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. CEM Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Thermo Fisher
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Creative Diagnostics
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Polypeptide Group
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Syngene
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. PuroSynth
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Lonza
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. MP Biomedicals And Novo Nordisk A/S.
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies